Center for Liver Disease

Charlotte, North Carolina 28204

0 studies enrolling now · 2 studies all time

What they study most

Non Alcoholic Steatohepatitis (NASH), Non-Alcoholic Steatohepatitis

Studies at this site

• Randomized Global Phase 3 Study to Evaluate the Impact on NASH With Fibrosis of Obeticholic Acid Treatment — Stopped early
• Volixibat (SHP626) in the Treatment of Adults With Nonalcoholic Steatohepatitis (NASH) — Stopped early